All In Biotech

Drug Trial Radar · NCT06752603

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

57

Actual

Start

Apr 2, 2025

Primary completion

Jun 12, 2026

Study completion Jun 12, 2026

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Dec 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Conditions

  • Hunner Type Interstitial Cystitis

Interventions

  • ONO-1110Drug

    ONO-1110 tablets once a day

  • PlaceboDrug

    Placebo tablets once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in weekly mean of average pain score from baseline to Week 12 of the treatment periodTime frame: Up to 20 weeks
  2. Adverse eventsTime frame: Up to 20 weeks

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Nagasaki University Hospital

    Nagasaki, Japan

  • Nagoya University Hospital

    Nagoya, Aichi-ken, Japan

  • Harasanshin Hospital

    Fukuoka, Fukuoka, Japan

  • Fukushima Medical University Hospital

    Fukushima, Fukushima, Japan

  • Japanese Red Cross Gifu Hospital

    Gifu, Gifu, Japan

  • Kurosawa Hospital Health Park Clinic

    Takasaki, Gunma, Japan

  • Niimura Hospital

    Kagoshima, Kagoshima-ken, Japan

  • Kanto Rosai Hospital

    Kawasaki, Kanagawa, Japan

  • Rakuwakai Marutamachi Hospital

    Kyoto, Kyoto, Japan

  • Ueda Clinic

    Kyoto, Kyoto, Japan

  • Izumi Chuo Hospital

    Sendai, Miyagi, Japan

  • Shinshu University Hospital

    Matsumoto, Nagano, Japan

  • Nakamura Hospital

    Beppu, Oita Prefecture, Japan

  • Okayama University Hospital

    Okayama, Okayama-ken, Japan

  • Nanri Urological Clinic

    Saga, Saga-ken, Japan

  • The Jikei University Hospital

    Minato-Ku, Tokyo, Japan

  • Kyorin University Hospital

    Mitaka, Tokyo, Japan

  • The University Of Tokyo Hospital

    Tokyo, Tokyo, Japan

  • Toyama Rosai Hospital

    Uozu, Toyama, Japan

  • University Of Yamanashi Hospital

    Chūō, Yamanashi, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.